RE:RE:RE:RE:Up, up, up she goes... Am I missing something or did the news release this morning actually completely gloss over any update on the trials they were working on? Instead its all dedicated to some new "discovery" while they were doing the trials. From the previous news release:
"With the successful dosing of these two product forms, the Company anticipates receiving the complete pharmacokinetic data from the ivermectin pre-clinical trials within the next two weeks. It is anticipated that the pharmacokinetic data will successfully document superior movement of the ivermectin drug into, through, and out of the body and the time course of its absorption, bioavailability, distribution and metabolism"
News release today:
"Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA:20MP) is pleased to announce that it confirmed the ability to make the drug ivermectin water-soluble without the use of organic solvents, which may enable the drug to be dosed by injection or inhalation in humans. "
It seems the company has decided to not reveal any of the pharmcokinetic data regarding these trials. Also note the language in the news release; the word 'believe' is used an incredible 11 times and the word potential "6 times"
We were all waiting on a news release and we got one. Unfortunately it did not provide any results or data from their pretrials. Instead fwe received a news release with a lot of fluff about the potential of a new discovery they believe to be significant and what sounds like another shift in company focus.